Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reimbursement News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Vertebroplasty/Kyphoplasty tech assessment

You may also be interested in...



Panel Supports Sapien But Urges Cautious Rollout

Edwards Lifesciences’ Sapien transcatheter aortic valve met widespread expectations last week by gaining support for FDA approval from an agency advisory panel, but the experts urged FDA and Edwards to proceed cautiously.

Medicare RVU Proposals Would Have Mixed Device Impact

New proposals for revisions to physician work “relative value units” for Medicare would have a mixed impact on payments for device-heavy procedures.

Proposed Rule For Physician Payment Reporting Expected By Summer

CMS's Office of Policy will issue a proposed rule as early as this summer explaining how companies should implement the physician payment reporting requirements authorized in the health reform law, an agency official said.

Related Content

Topics

UsernamePublicRestriction

Register

SC143420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel